Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

DBV Submits VIASKIN Peanut Patch for FDA Approval Following Phase 3 Success

Aquestive Resubmits Needle-Free Sublingual Epinephrine to FDA for Approval

Potential Breakthrough for Celiac Disease: Teva Antibody Significantly Reduces Gluten-Induced Gut Damage

Rare Antibodies Could Lead to First Targeted Treatment for Alpha-Gal Syndrome

Another Potential Food Allergy Treatment is Snapped Up by Big Pharma

Intrommune’s Toothpaste Immunotherapy for Peanut Allergy Completes Phase 1 Enrollment

FDA Accepts New Drug Application for Nasal Epinephrine Spray Treatment for...

Aquestive Receives Positive FDA Response to Epinephrine Sublingual Film Phase 2...

Gene Therapy Successfully Treats Mice with Food Allergies

Aquestive’s Sublingual Emergency Epinephrine Compares Favorably to EpiPen® in EPIPHAST II...

Private Law Firm to Investigate Claims on Behalf of Investors in...

FDA Issues Partial Hold on DBV Viaskin Peanut Patch Trial

Study Finds Biologic Drug Highly Effective in Reducing Pediatric Eczema Symptoms

DBV Begins Phase 3 Study of Redesigned Viaskin Peanut Patch in...

Bryn Pharma Completes Study of Nasal Epinephrine vs Auto-Injector for Anaphylaxis

Follow Us

Your School On Our Map

Put Your School on the Map